Ana F. Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana F. Costa has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Kayla G. Sprenger
Department of Chemical and Biological Engineering University of Colorado Boulder Boulder Colorado USA
2 shared publications - Anlan Chen
Department of Mechanical Engineering and Materials Science, Duke University, Durham, USA
1 shared publication Ashkon E. Chaghajerdi
Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, CO, USA
1 shared publication- Cynthia Rudin
Duke University, Durham, NC, USA
1 shared publication Daisy I. Fuchs
Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, CO, USA
1 shared publication- David Saeb
Department of Chemical and Biological Engineering, University of Colorado Boulder
1 shared publication
Latest Publications
- Open Access
Investigating the therapeutic potential of soluble TREM2 interactions with transgelin-2 in Alzheimer’s disease
Triggering receptor expressed on myeloid cells 2 (TREM2) is a regulator of microglial function in Alzheimer’s disease (AD), and its soluble ectodomain (sTREM2) has emerged as a potential neuroprotective factor. Recent work shows that sTREM2 exerts protective effects through direct interaction with neuronal transgelin-2 (TG2) and modulates downstream tau pathology, yet the molecular basis of this interaction remains unknown. Here, we use all-atom molecular dynamics simulations to define the structural mechanisms of sTREM2–TG2 binding. We identify an electrostatically driven interface centered on the TG2 calponin homology domain. This surface is engaged by a binding motif on sTREM2 in which charged anchoring residues are flanked by hydrophobic contacts. We further show that the AD-risk TREM2 R47H variant maintains a more open, solvent-exposed CDR2 loop that redistributes interfacial contacts while preserving overall binding affinity, offering a structural explanation for reports that R47H does not exacerbate tau pathology in tauopathy models. Leveraging these insights, we design optimized sTREM2-derived peptides that outperform a previously reported therapeutic peptide in binding persistence, energetics, and recapitulation of native TG2 contacts, supporting engagement at the epitope through which sTREM2 suppresses tau phosphorylation. Taken together, our results define a mechanistic framework for the sTREM2–TG2 axis in AD and establish a structure-guided strategy for developing peptide modulators of this interaction.
Open AccessInvestigating the therapeutic potential of soluble TREM2 interactions with transgelin-2 in Alzheimer’s disease
Triggering receptor expressed on myeloid cells 2 (TREM2) is a regulator of microglial function in Alzheimer’s disease (AD), and its soluble ectodomain (sTREM2) has emerged as a potential neuroprotective factor. Recent work shows that sTREM2 exerts protective effects through direct interaction with neuronal transgelin-2 (TG2) and modulates downstream tau pathology, yet the molecular basis of this interaction remains unknown. Here, we use all-atom molecular dynamics simulations to define the structural mechanisms of sTREM2–TG2 binding. We identify an electrostatically driven interface centered on the TG2 calponin homology domain. This surface is engaged by a binding motif on sTREM2 in which charged anchoring residues are flanked by hydrophobic contacts. We further show that the AD-risk TREM2 R47H variant maintains a more open, solvent-exposed CDR2 loop that redistributes interfacial contacts while preserving overall binding affinity, offering a structural explanation for reports that R47H does not exacerbate tau pathology in tauopathy models. Leveraging these insights, we design optimized sTREM2-derived peptides that outperform a previously reported therapeutic peptide in binding persistence, energetics, and recapitulation of native TG2 contacts, supporting engagement at the epitope through which sTREM2 suppresses tau phosphorylation. Taken together, our results define a mechanistic framework for the sTREM2–TG2 axis in AD and establish a structure-guided strategy for developing peptide modulators of this interaction.
- 11 November 2025
- Published by Springer Nature in MRS Bulletin
- Vol. 50 (11) , 1376-1390
From biomatter to bioplastics: A perspective on modeling, structure, and data-driven design
- 11 November 2025
- Published by Springer Nature in MRS Bulletin
- Vol. 50 (11) , 1376-1390
From biomatter to bioplastics: A perspective on modeling, structure, and data-driven design